Skip to main content

Table 3 HLA profiles of patients affected by BSS

From: Immunological features of patients affected by Barraquer-Simons syndrome

Patient
BSS1A*01:01,*30:02B*08:01,*18:01C*05:01,*07:01DRB1*03:01DQB1*02:01DQA1*05:01DPB1*01:01,*02:02
BSS2A*02:01,*11:01B*35:01,*57:03/B*35:04,*57:01C*04:01,*07:01DRB1*11:03,*14:54DQB1*03:01,*05:03DQA1*01:04,*05:05/09DPB1*04:01
BSS3A*03:01,*11:01B*27:05,*35:01C*01:02,*04:01DRB1*01:01,*04:03DQB1*03:02,*05:01DQA1*01:01,*03:01DPB1*04:01
BSS4A*02:01,*24:02B*40:06,*49:01C*07:01,*15:02DRB1*01:01,*11:03DQB1*03:01,*05:01DQA1*01:01,*05:05/09DPB1*02:01,*04:01
BSS5A*03:01,*29:02B*18:01,*44:02C*05:01DRB1*03:01,*11:01DQB1*02:01,*03:01DQA1*05:01,*05:05/09DPB1*04:01
BSS6A*11:01,*24:02B*53:01,*57:01C*04:01,*06:02DRB1*07:01,*13:02DQB1*03:03,*06:04DQA1*01:02,*02:01DPB1*03:01,*04:02
BSS7A*29:02,*68:01B*44:02,*49:01C*07:01,*07:04DRB1*04:01,*07:01DQB1*02:02,*03:01DQA1*02:01,*03:01DPB1*04:01
BSS8A*02:01,*24:02B*15:01,*41:02C*03:03,*17:01/17:03DRB1*11:03,*13:03DQB1*03:01DQA1*05:05/09DPB1*04:01,*04:02
BSS9A*32:01,*68:01B*35:08,*51:01C*04:01,*15:02DRB1*04:03,*13:01DQB1*03:02,*06:03DQA1*01:03,*03:01DPB1*02:01,*04:01
BSS10A*02:01,*24:02B*15:01,*18:01C*03:03,*12:03DRB1*04:01,*11:04DQB1*03:01,*03:02DQA1*03:01,*05:05/09n.s.
BSS11A*02:01,*24:02B*35:01,*45:01C*04:01,*07:02DRB1*11:01,*11:03DQB1*03:01DQA1*05:05/09n.s.
BSS12A*02:01B*27:05,*39:06C*02:02,*07:02DRB1*08:01,*13:01DQB1*04:02,*06:03DQA1*01:03,*04:01n.s.
BSS13A*02:01,*11:01B*44:02,*55:01C*03:03,*05:01DRB1*10:01,*16:01DQB1*05:01,*05:02DQA1*01:01/04/05,*01:02n.s.
  1. The most likely HLA alleles at four-digit resolution, assigned as indicated in Materials and Methods, are displayed for each patient. Slashes represent ambiguities in the phenotype; n.s. not studied